Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 6, 2022
What Have Failed, Interrupted, and Withdrawn Antibody Therapies in Multiple Sclerosis Taught Us?Julia Krämer, Heinz Wiendl
Current Opinion in Neurology|March 27, 2024
Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectationsJulia Krämer, Heinz Wiendl
Nature Reviews. Neurology|April 13, 2023
Bruton tyrosine kinase inhibitors for multiple sclerosisJulia Krämer, Amit Bar-Or, Timothy J Turner, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|August 8, 2025
Oromandibular Dystonia and Dysphagia in Hyperglycemic Brainstem DysfunctionGero Lueg, Timm Westhoff, Martin Fruth, et al.
Plos One|October 7, 2016
Dichoptic Metacontrast Masking Functions to Infer Transmission Delay in Optic NeuritisMaximilian Bruchmann, Catharina Korsukewitz, Julia Krämer, et al.
Journal of the Neurological Sciences|July 20, 2015
Recovery of thalamic microstructural damage after Shiga toxin 2-associated hemolytic-uremic syndromeJulia Krämer, Michael Deppe, Kerstin Göbel, et al.
Progress in Neurobiology|August 3, 2019
Imaging in mice and men: Pathophysiological insights into multiple sclerosis from conventional and advanced MRI techniquesJulia Krämer, Wolfgang Brück, Frauke Zipp, et al.
International Journal of Molecular Sciences|September 26, 2015
Early and Degressive Putamen Atrophy in Multiple SclerosisJulia Krämer, Sven G Meuth, Jan-Gerd Tenberge, et al.
Journal of the Neurological Sciences|April 23, 2017
Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patientsChristoph Heesen, Ingo Kleiter, Sven G Meuth, et al.
Pageof 5